ATyr Pharma Current Ratio 2014-2021 | LIFE

ATyr Pharma current ratio from 2014 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ATyr Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.05B $0.01B 6.37
2021-03-31 $0.05B $0.00B 11.71
2020-12-31 $0.04B $0.01B 6.06
2020-09-30 $0.04B $0.01B 4.76
2020-06-30 $0.04B $0.01B 4.47
2020-03-31 $0.05B $0.01B 4.82
2019-12-31 $0.03B $0.01B 2.47
2019-09-30 $0.04B $0.01B 3.31
2019-06-30 $0.04B $0.01B 3.88
2019-03-31 $0.05B $0.01B 4.00
2018-12-31 $0.05B $0.01B 4.69
2018-09-30 $0.06B $0.01B 5.38
2018-06-30 $0.07B $0.01B 5.95
2018-03-31 $0.08B $0.01B 6.90
2017-12-31 $0.09B $0.01B 8.37
2017-09-30 $0.09B $0.01B 9.49
2017-06-30 $0.06B $0.01B 6.13
2017-03-31 $0.06B $0.01B 9.74
2016-12-31 $0.08B $0.01B 8.77
2016-09-30 $0.07B $0.01B 6.17
2016-06-30 $0.09B $0.01B 6.17
2016-03-31 $0.09B $0.01B 6.64
2015-12-31 $0.10B $0.01B 8.06
2015-09-30 $0.11B $0.01B 12.69
2015-06-30 $0.11B $0.01B 11.33
2015-03-31 $0.06B $0.01B 4.78
2014-12-31 $0.02B $0.01B 1.63
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.04B $0.01B 7.12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.144B $0.010B
aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76